Bill Text: NY A04367 | 2025-2026 | General Assembly | Introduced

---

Bill Title: Relates to cannabinoid hemp retail sales and retailers; makes technical changes to the definition of THC; provides specific requirements for labeling of cannabinoid hemp products.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2025-02-04 - referred to economic development [A04367 Detail]

Download: New_York-2025-A04367-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          4367

                               2025-2026 Regular Sessions

                   IN ASSEMBLY

                                    February 4, 2025
                                       ___________

        Introduced  by  M. of A. FALL -- read once and referred to the Committee
          on Economic Development

        AN ACT to amend the cannabis law, in relation to cannabinoid hemp retail
          sales and retailers

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section 1. Subdivisions 52 and 53 of section 3 of the cannabis law are
     2  amended to read as follows:
     3    52.  "THC" means Delta-9-tetrahydrocannabinol[; Delta-8-tetrahydrocan-
     4  nabinol; Delta-10-tetrahydrocannabinol and the optical  isomer  of  such
     5  substances].
     6    53.  "Total  THC" means the [sum of the percentage by weight or volume
     7  measurement of tetrahydrocannabinolic acid multiplied  by  0.877,  plus,
     8  the  percentage by weight or volume measurement of THC] dry weight total
     9  percentage of Delta-9-tetrahydrocannabinol in each product.
    10    § 2. The opening paragraph and subdivision 13 of  section  91  of  the
    11  cannabis law is amended to read as follows:
    12    The  board,  without  infringing on licensed retailers, may make regu-
    13  lations pursuant to  this  article  for  the  processing,  distribution,
    14  marketing, transportation and sale of cannabinoid hemp and hemp extracts
    15  used for human consumption, which may include, but not be limited to:
    16    13.  Any cannabinoid hemp flower product clearly labeled or advertised
    17  for the purposes of smoking, or in the form of a  cigarette,  cigar,  or
    18  pre-roll,  or  packaged or combined with other items designed to facili-
    19  tate smoking such as rolling papers or pipes, shall only be offered  for
    20  sale  [in  adult-use  cannabis  retail dispensaries licensed pursuant to
    21  article four of this chapter] to those individuals twenty-one  years  of
    22  age and older.
    23    §  3.  Subdivision  2 of section 103 of the cannabis law is amended to
    24  read as follows:

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD08725-01-5
        A. 4367                             2

     1    2. The board may, by rules  and  regulations,  require  processors  to
     2  establish  a code, including, but not limited to QR code, for labels and
     3  establish methods and procedures for determining,  among  other  things,
     4  serving sizes or dosages for cannabinoid hemp, hemp extract and products
     5  derived  therefrom,  active  cannabinoid concentration per serving size,
     6  number of servings per container, and the growing region, state or coun-
     7  try of origin if not from the United States. Such rules and  regulations
     8  may  require  an appropriate fact panel that incorporates data regarding
     9  serving sizes and potency thereof; provided, however, and  notwithstand-
    10  ing  any  statute, rule, or regulation to the contrary, all hemp-derived
    11  cannabinoid products shall meet the following labeling requirements:
    12    (a) a nutrition label with serving size;
    13    (b) a warning label that the product is not meant to treat or cure any
    14  medical ailment and that such product is not regulated by the FDA;
    15    (c) the amount of hemp derived product in each serving of the  product
    16  in milligrams; and
    17    (d) the address of the manufacturer or distributor.
    18    § 4. This act shall take effect immediately.